{"id":"W4411732624","doi":"10.1093/bjd/ljaf085.132","title":"P104 Lebrikizumab improves quality of life in patients with moderate-to-severe atopic dermatitis inadequately controlled or ineligible for ciclosporin (ADvantage study)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; Dermatology; Quality of life (healthcare); Pediatrics; Surgery; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006034399,0.0003386697,0.0008950317,0.000141578,0.0001793422,0.0004050545,0.0002276848,0.0003716114,0.002280491],"category_scores_gemma":[0.0004872801,0.0001367198,0.0007893976,0.0001510005,0.0001813896,0.0002775743,0.0001916665,0.0006468256,0.0001695353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002286145,"about_ca_system_score_gemma":0.0002161023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000336952,"about_ca_topic_score_gemma":0.0009186101,"domain_scores_codex":[0.9998143,0.00009151277,0.00001682232,0.00002284725,0.0000213376,0.00003318253],"domain_scores_gemma":[0.9997122,0.00007344749,0.00008379371,0.00001589692,0.00002082282,0.00009382768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6254531,0.02078682,0.1612668,0.001746204,0.002776965,0.0006263426,0.00021762,0.0005948297,0.02285337,0.0001942435,0.004500078,0.1589836],"study_design_scores_gemma":[0.1943065,0.3559105,0.439306,0.0002371183,0.001583829,0.001058022,0.0002179121,0.001503187,0.00227371,0.0001504458,0.003418576,0.00003418233],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963939,0.002532148,0.00003780852,0.0001127923,0.00003002229,0.0001112739,0.0002019304,0.00000860184,0.000571583],"genre_scores_gemma":[0.998747,0.0004608594,0.00009794124,0.0001562856,0.00004095145,0.00007573186,0.0002164995,0.000001007053,0.0002036773],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002280491,"threshold_uncertainty_score":0.007629037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01427100461718956,"score_gpt":0.3019468639665219,"score_spread":0.2876758593493324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}